🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Patient-Reported Outcomes and Complications After Structural Rhinoplasty Using Septal Extension Grafts

Recruitingn/aAges 18 Years - anyAllCumhuriyet University Hospital
NCT07531810 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Structural rhinoplasty with septal extension graft (SEG) is commonly used to achieve stable nasal tip support and predictable long-term outcomes. However, surgical success is not limited to structural stability alone and should also be evaluated from the patient's perspective. Patient-reported outcome measures (PROMs) have gained increasing importance in rhinoplasty, as they reflect patient satisfaction and perceived nasal function. Despite the widespread use of SEG, prospective studies evaluating PROMs together with postoperative clinical findings over time remain limited. This prospective observational cohort study aims to evaluate longitudinal changes in patient-reported outcomes and postoperative findings in adult patients undergoing primary structural rhinoplasty with SEG-based nasal tip support. Validated PROM instruments will be applied preoperatively and during routine postoper

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 18 years or older * Undergoing primary structural rhinoplasty with septal extension graft * Able to understand and complete patient-reported outcome questionnaires (PROMs) * Willing to participate and provide written informed consent Exclusion Criteria: * History of previous nasal surgery (revision rhinoplasty) * Undergoing concomitant major craniofacial procedures * Missing preoperative PROM data * Unable to complete postoperative follow-up assessments
💊

What it tests

  • Not listed
📍

Where

1 site
Sivas Cumhuriyet University
Sivas, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy